Cargando…

Correction to Lancet Oncol 2022; 23: 125–37

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Pub. Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822394/
https://www.ncbi.nlm.nih.gov/pubmed/35114129
http://dx.doi.org/10.1016/S1470-2045(22)00029-8
_version_ 1784646600846475264
collection PubMed
description
format Online
Article
Text
id pubmed-8822394
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lancet Pub. Group
record_format MEDLINE/PubMed
spelling pubmed-88223942022-02-11 Correction to Lancet Oncol 2022; 23: 125–37 Lancet Oncol Corrections Lancet Pub. Group 2022-02 /pmc/articles/PMC8822394/ /pubmed/35114129 http://dx.doi.org/10.1016/S1470-2045(22)00029-8 Text en © 2022 The Author(s). Published by Elsevier Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Corrections
Correction to Lancet Oncol 2022; 23: 125–37
title Correction to Lancet Oncol 2022; 23: 125–37
title_full Correction to Lancet Oncol 2022; 23: 125–37
title_fullStr Correction to Lancet Oncol 2022; 23: 125–37
title_full_unstemmed Correction to Lancet Oncol 2022; 23: 125–37
title_short Correction to Lancet Oncol 2022; 23: 125–37
title_sort correction to lancet oncol 2022; 23: 125–37
topic Corrections
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822394/
https://www.ncbi.nlm.nih.gov/pubmed/35114129
http://dx.doi.org/10.1016/S1470-2045(22)00029-8